Fidelity Investments’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-118,794
Closed -$18M 5728
2022
Q3
$18M Buy
118,794
+1,286
+1% +$194K ﹤0.01% 1648
2022
Q2
$17.1M Sell
117,508
-1,434,343
-92% -$209M ﹤0.01% 1711
2022
Q1
$184M Buy
1,551,851
+41,001
+3% +$4.86M 0.01% 819
2021
Q4
$208M Buy
1,510,850
+229,600
+18% +$31.6M 0.02% 793
2021
Q3
$178M Buy
1,281,250
+141,076
+12% +$19.6M 0.01% 857
2021
Q2
$111M Buy
1,140,174
+21,950
+2% +$2.13M 0.01% 1081
2021
Q1
$76.4M Sell
1,118,224
-235,913
-17% -$16.1M 0.01% 1191
2020
Q4
$116M Sell
1,354,137
-25,880
-2% -$2.22M 0.01% 961
2020
Q3
$89.7M Buy
1,380,017
+27,603
+2% +$1.79M 0.01% 962
2020
Q2
$98.9M Buy
1,352,414
+562,071
+71% +$41.1M 0.01% 878
2020
Q1
$26.9M Buy
790,343
+90,064
+13% +$3.06M ﹤0.01% 1287
2019
Q4
$38.1M Hold
700,279
﹤0.01% 1328
2019
Q3
$29.2M Buy
700,279
+360,916
+106% +$15.1M ﹤0.01% 1419
2019
Q2
$14.9M Sell
339,363
-117,004
-26% -$5.12M ﹤0.01% 1737
2019
Q1
$23.5M Sell
456,367
-384,865
-46% -$19.8M ﹤0.01% 1533
2018
Q4
$31.1M Sell
841,232
-57,600
-6% -$2.13M ﹤0.01% 1375
2018
Q3
$33.8M Sell
898,832
-455,232
-34% -$17.1M ﹤0.01% 1466
2018
Q2
$53.5M Buy
1,354,064
+846,141
+167% +$33.4M 0.01% 1245
2018
Q1
$13.1M Sell
507,923
-527,600
-51% -$13.6M ﹤0.01% 1873
2017
Q4
$27.9M Hold
1,035,523
﹤0.01% 1562
2017
Q3
$38.7M Hold
1,035,523
﹤0.01% 1421
2017
Q2
$25.9M Buy
+1,035,523
New +$25.9M ﹤0.01% 1574